ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302325; 2) Community: the network communities that were significantly associated with the response to NSC 302325; 3) Molecule: the relationships between components within communities and NSC 302325; 4) MDR: the compounds that were significantly associated with the NSC 302325.

NSC Compound Enrichment Correlation
NSC 728132 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene 0.0038671642008129 0.33679171
NSC 736988 6-(3-Aminopropyl)-5,6-dihydro-9-methoxy-5,11-dioxo-11H-inden o[1,2-c]isoquinoline Hydrochloride 0.0038671642008129 0.59061243
NSC 737671 6-(3-Aminopropyl)-5,6-dihbydro-3-nitro-5,11-dioxo-9-phenyl-1 1H[1,2-c]isoquinoline Hydrochloride 0.0038671642008129 0.54727077
NSC 10660 Null 0.00396536695012846 0.34804454
NSC 115980 Null 0.00396536695012846 0.40004237
NSC 12150 Decanediamine, N,N'-bis(4-amino-2-methyl-6-quinolinyl)-, dihydrochloride 0.00396536695012846 0.19022681
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.00396536695012846 -0.037643316
NSC 339578 Null 0.00396536695012846 0.73765334
NSC 372950 Null 0.00396536695012846 0.77549216
NSC 381866 BAFILOMYCIN DERIV. 0.00396536695012846 0.54691046
Total:151  Current:28    [First] [Prev] [Next] [Last]